Literature DB >> 26142130

Guidelines for Writing Letters to Patients.

Diane L Baker1, Timothy Eash, Jane L Schuette, Wendy R Uhlmann.   

Abstract

Patient letters provide a permanent record of the genetic counseling that was provided and are unique in medical care; rarely do other health care providers send summaries written specifically to their patients and families. We surveyed genetic counseling training program directors and found that while the acquisition of patient letter-writing skills was considered important, there were no specific guidelines made available to students. To develop letter-writing guidelines, we evaluated patient letters, reviewed references on professional correspondence, surveyed the medical literature, and worked with a writing consultant. The guidelines we subsequently developed and present here include a format for writing patient letters, suggestions on presenting medical information in understandable terms, and wording considerations. These patient letter-writing guidelines are intended to serve as a guide for teaching students this important skill and as a resource for practicing health care professionals.

Entities:  

Year:  2002        PMID: 26142130     DOI: 10.1023/A:1016841731426

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  2 in total

1.  National Society of Genetic Counselors code of ethics.

Authors: 
Journal:  J Genet Couns       Date:  1992-03       Impact factor: 2.537

2.  The value of written summaries of genetic consultations.

Authors:  N Hallowell; F Murton
Journal:  Patient Educ Couns       Date:  1998-09
  2 in total
  13 in total

1.  GenIE: an intelligent system for writing genetic counseling patient letters.

Authors:  Nancy Green
Journal:  AMIA Annu Symp Proc       Date:  2005

2.  The Genetics Journey: A Case Report of a Genetic Diagnosis Made 30 Years Later.

Authors:  Linford A Williams; Shane C Quinonez; Wendy R Uhlmann
Journal:  J Genet Couns       Date:  2017-06-13       Impact factor: 2.537

3.  From the laboratory to the clinic: sharing BRCA VUS reclassification tools with practicing genetics professionals.

Authors:  Bianca M Augusto; Paige Lake; Courtney L Scherr; Fergus J Couch; Noralane M Lindor; Susan T Vadaparampil
Journal:  J Community Genet       Date:  2017-11-09

4.  Assessment of clinical practices among cancer genetic counselors.

Authors:  Deborah Wham; Thuy Vu; Gayun Chan-Smutko; Christine Kobelka; Diana Urbauer; Brandie Heald
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

5.  A survey of patients' experiences with the cancer genetic counseling process: recommendations for cancer genetics programs.

Authors:  Dana T Kausmeyer; Eugene J Lengerich; Brenda C Kluhsman; Dorothy Morrone; Gregory R Harper; Maria J Baker
Journal:  J Genet Couns       Date:  2006-12       Impact factor: 2.537

6.  The Long and Short of Genetic Counseling Summary Letters: A Case-control Study.

Authors:  J Roggenbuck; R Temme; D Pond; J Baker; K Jarvis; M Liu; S Dugan; N J Mendelsohn
Journal:  J Genet Couns       Date:  2014-12-14       Impact factor: 2.537

7.  Assessment of the Readability of Genetic Counseling Patient Letters.

Authors:  Emily Brown; Megan Skinner; Stephanie Ashley; Kate Reed; Shannan DeLany Dixon
Journal:  J Genet Couns       Date:  2015-09-29       Impact factor: 2.537

8.  The importance of written information packages in support of case-finding within families at risk for inherited high cholesterol.

Authors:  Hélène W P van den Nieuwenhoff; Ilse Mesters; Joyce J T M Nellissen; Anton F Stalenhoef; Nanne K de Vries
Journal:  J Genet Couns       Date:  2006-02       Impact factor: 2.537

9.  Assessment of Current Genetic Counselor Practices in Post-Visit Written Communications to Patients.

Authors:  Emily VandenBoom; Angela M Trepanier; Erin P Carmany
Journal:  J Genet Couns       Date:  2017-10-12       Impact factor: 2.537

Review 10.  Reconsidering the duty to warn genetically at-risk relatives.

Authors:  Mark A Rothstein
Journal:  Genet Med       Date:  2018-02-01       Impact factor: 8.822

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.